Comment from Informed Consent Action Network

Summary: The Informed Consent Action Network (ICAN) opposes the licensure of Moderna's mRNA influenza vaccine, Mflusiva, citing an unfavorable benefit-risk ratio, concerning safety signals (including cardiac and hematologic risks), and a lack of clinically meaningful evidence of efficacy compared to current standards of care for older adults. They urge the committee to require additional clinical investigation before granting licensure.